| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
106.75(B) |
| Last
Volume: |
6,978,222 |
Avg
Vol: |
8,439,653 |
| 52
Week Range: |
$48.64 - $74.55 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
131,028 |
294,034 |
784,747 |
1,896,260 |
| Total Sell Value |
$9,081,880 |
$18,529,068 |
$44,400,077 |
$93,901,157 |
| Total People Sold |
8 |
9 |
11 |
13 |
| Total Sell Transactions |
13 |
22 |
38 |
73 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mario Ernest |
Director |
– • – |
2011-08-03 |
4 |
B |
$6.70 |
$670 |
I/I |
100 |
22,600 |
2.02 |
- |
|
| Mario Ernest |
Director |
– • – |
2011-08-02 |
4 |
B |
$6.82 |
$682,230 |
D/D |
100,000 |
231,004 |
2.39 |
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2011-08-01 |
4 |
D |
$6.92 |
$7,916 |
D/D |
(1,144) |
43,280 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2011-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,118 |
44,424 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, CRM |
• – – |
2011-07-29 |
4 |
D |
$7.16 |
$15,616 |
D/D |
(2,181) |
57,551 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, CRM |
• – – |
2011-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
59,732 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2011-07-29 |
4 |
D |
$7.16 |
$10,948 |
D/D |
(1,529) |
41,306 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2011-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
42,835 |
|
- |
|
| Burns Brian R |
EVP - Global Quality & Reg Aff |
• – – |
2011-07-01 |
4 |
D |
$7.23 |
$18,364 |
D/D |
(2,540) |
62,381 |
|
- |
|
| Burns Brian R |
EVP - Global Quality & Reg Aff |
• – – |
2011-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
64,921 |
|
- |
|
| Phalen Michael P. |
EVP & President, International |
• – – |
2011-07-01 |
4 |
D |
$7.23 |
$6,044 |
D/D |
(836) |
41,862 |
|
- |
|
| Phalen Michael P. |
EVP & President, International |
• – – |
2011-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,630 |
42,698 |
|
- |
|
| Pucel Kenneth |
EVP, Global Ops & Technology |
• – – |
2011-07-01 |
4 |
D |
$7.23 |
$18,914 |
D/D |
(2,616) |
86,350 |
|
- |
|
| Pucel Kenneth |
EVP, Global Ops & Technology |
• – – |
2011-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
88,966 |
|
- |
|
| Pedersen John B. |
Pres, Uro & Womens Health |
• – – |
2011-07-01 |
4 |
D |
$7.23 |
$6,934 |
D/D |
(959) |
2,061 |
|
- |
|
| Pedersen John B. |
Pres, Uro & Womens Health |
• – – |
2011-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,020 |
3,020 |
|
- |
|
| Kucheman William |
EVP & Group Pres, CRV |
• – – |
2011-07-01 |
4 |
D |
$7.23 |
$9,876 |
D/D |
(1,366) |
71,305 |
|
- |
|
| Kucheman William |
EVP & Group Pres, CRV |
• – – |
2011-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,300 |
72,671 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2011-07-01 |
4 |
D |
$7.23 |
$3,311 |
D/D |
(458) |
62,395 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2011-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
62,853 |
|
- |
|
| Moreci Stephen F |
SVP, Global Sales Operations |
• – – |
2011-07-01 |
4 |
D |
$7.23 |
$18,364 |
D/D |
(2,540) |
37,362 |
|
- |
|
| Moreci Stephen F |
SVP, Global Sales Operations |
• – – |
2011-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
39,902 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2011-06-20 |
4 |
D |
$6.74 |
$2,238 |
D/D |
(332) |
61,453 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2011-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,013 |
61,785 |
|
- |
|
| Phalen Michael P. |
EVP & President, International |
• – – |
2011-06-20 |
4 |
D |
$6.74 |
$4,071 |
D/D |
(604) |
40,068 |
|
- |
|
1846 Records found
|
|
Page 24 of 74 |
|
|
0.10 (0.13%) 
